학술논문

TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Document Type
Article
Source
In: Pathology Research and Practice. (Pathology Research and Practice, January 2024, 253)
Subject
Language
English
ISSN
16180631
03440338